|
Re: Explanation of difference between Endcrinology and CVD
|
7
|
Resverlogix Corp.
|
Oct 06, 2015 02:51PM
|
|
Cowen presentation significance
|
8
|
Resverlogix Corp.
|
Mar 14, 2017 03:27AM
|
|
Re: Let the game begin
|
8
|
Resverlogix Corp.
|
Apr 01, 2020 09:39AM
|
|
Re: Does anyone here know personally the poster tundup,..?
|
8
|
Resverlogix Corp.
|
Apr 26, 2019 01:49PM
|
|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
8
|
Resverlogix Corp.
|
Jun 12, 2020 02:33PM
|
|
The positive view
|
8
|
Resverlogix Corp.
|
Oct 13, 2017 12:29PM
|
|
Re: Resverlogix_150929_C... (Rough, UNOFFICIAL transcript)
|
8
|
Resverlogix Corp.
|
Oct 02, 2015 09:10AM
|
|
Roth research report
|
9
|
Resverlogix Corp.
|
Oct 31, 2018 04:21PM
|
|
Re: Looks like 0 participation in warrant incentive imo - answer to my email...
|
9
|
Resverlogix Corp.
|
Jan 18, 2020 05:54AM
|
|
Re: A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease
|
9
|
Resverlogix Corp.
|
Sep 27, 2015 11:11AM
|
|
Re: Citigroup note on Epigenetics - a big initiation note published on 22 October
|
9
|
Resverlogix Corp.
|
Oct 27, 2015 09:36AM
|
|
Braveheart
|
9
|
Resverlogix Corp.
|
Sep 21, 2015 02:30PM
|
|
Citigroup note on Epigenetics - a big initiation note published on 22 October
|
9
|
Resverlogix Corp.
|
Oct 26, 2015 08:59AM
|
|
Re: Positives & negatives
|
9
|
Resverlogix Corp.
|
Sep 16, 2015 04:33PM
|
|
Question on EMA vs FDA
|
10
|
Resverlogix Corp.
|
Sep 30, 2015 09:32AM
|
|
Re: BearDown, Ledenfrog, Tundup and all other experts.....
|
10
|
Resverlogix Corp.
|
Oct 20, 2015 04:34AM
|
|
Re: A new mathematical formula for RVX
|
10
|
Resverlogix Corp.
|
Nov 06, 2015 12:25PM
|
|
Re: Positives & negatives
|
10
|
Resverlogix Corp.
|
Sep 16, 2015 03:40PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
12
|
Resverlogix Corp.
|
Jun 21, 2018 01:39PM
|
|
Expectations
|
12
|
Resverlogix Corp.
|
Sep 17, 2019 02:41PM
|
